Hiroshima Bio-Medical ^None

Hiroshima Bio-Medical is a biotechnology company founded in 2007 that focuses on developing proprietary technologies related to antibody engineering and transgenic animal engineering using chickens. The company has a strong foundation in the Laboratory of Immunobiology at Hiroshima University.